Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibhuti Singh

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Annals of Internal Medicine|May 19, 2010
ACP Journal Club. Good evidence supports use of ACE inhibitors in stable ischemic heart disease; little evidence exists for ARBsVibhuti Singh
Annals of Internal Medicine|July 18, 2012
ACP Journal Club. Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressureVibhuti Singh
Indian Heart Journal|March 9, 2006
Coronary artery disease in South Asians: evolving strategies for treatment and preventionPrakash Deedwania, Vibhuti Singh
Current Atherosclerosis Reports|February 4, 2006
Dyslipidemia in special populations: Asian Indians, African Americans, and HispanicsVibhuti Singh, Prakash Deedwania
Drugs of Today (Barcelona, Spain : 1998)|July 4, 2008
Expanding roles for atorvastatinVibhuti Singh, Prakash Deedwania
Vascular Health and Risk Management|September 23, 2010
Atherogenic dyslipidemia and diabetes mellitus: what's new in the management arena?Ajoy Kumar, Vibhuti Singh
Vascular Health and Risk Management|June 26, 2009
Reducing morbidity and mortality in high risk patients with statinsVibhuti Singh, Prakash Deedwania
The American Journal of Cardiology|November 10, 2009
Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trialsPrakash Deedwania, Vibhuti Singh, Michael H Davidson
Vascular Health and Risk Management|December 4, 2010
Low high-density lipoprotein cholesterol: current status and future strategies for managementVibhuti Singh, Rakesh Sharma, Ajoy Kumar, et al.
European Journal of Immunology|July 6, 2011
Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cellsVibhuti Singh, Ulrike Mueller, Pia Freyschmidt-Paul, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Annals of Internal Medicine|May 19, 2010
ACP Journal Club. Good evidence supports use of ACE inhibitors in stable ischemic heart disease; little evidence exists for ARBsVibhuti Singh
Annals of Internal Medicine|July 18, 2012
ACP Journal Club. Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressureVibhuti Singh
Indian Heart Journal|March 9, 2006
Coronary artery disease in South Asians: evolving strategies for treatment and preventionPrakash Deedwania, Vibhuti Singh
Current Atherosclerosis Reports|February 4, 2006
Dyslipidemia in special populations: Asian Indians, African Americans, and HispanicsVibhuti Singh, Prakash Deedwania
Drugs of Today (Barcelona, Spain : 1998)|July 4, 2008
Expanding roles for atorvastatinVibhuti Singh, Prakash Deedwania
Vascular Health and Risk Management|September 23, 2010
Atherogenic dyslipidemia and diabetes mellitus: what's new in the management arena?Ajoy Kumar, Vibhuti Singh
Vascular Health and Risk Management|June 26, 2009
Reducing morbidity and mortality in high risk patients with statinsVibhuti Singh, Prakash Deedwania
The American Journal of Cardiology|November 10, 2009
Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trialsPrakash Deedwania, Vibhuti Singh, Michael H Davidson
Vascular Health and Risk Management|December 4, 2010
Low high-density lipoprotein cholesterol: current status and future strategies for managementVibhuti Singh, Rakesh Sharma, Ajoy Kumar, et al.
European Journal of Immunology|July 6, 2011
Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cellsVibhuti Singh, Ulrike Mueller, Pia Freyschmidt-Paul, et al.
Pageof 2